This constitutive overexpression suggests that ASCT2 is intrinsically driven by oncogenic signaling in SS, ensuring that the target for V9302 remains present even within the fluctuating nutrient gradients of the tumor microenvironment. This evidence concerns the gene SLC1A5 and neoplasm.